ENDOTHELIUM-INDEPENDENT CONTRACTIONS OF HUMAN CEREBRAL-ARTERIES IN RESPONSE TO VASOPRESSIN

被引:50
作者
DEAGUILERA, EM [1 ]
VILA, JM [1 ]
IRURZUN, A [1 ]
MARTINEZ, MC [1 ]
CUESTA, MAM [1 ]
LLUCH, S [1 ]
机构
[1] UNIV VALENCIA,FAC FARM,DEPT FISIOL,AVE BLASCO IBANEZ 13,E-46010 VALENCIA,SPAIN
关键词
CEREBRAL ARTERIES; ENDOTHELIUM; VASCULAR; VASOPRESSINS;
D O I
10.1161/01.STR.21.12.1689
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We studied the effects of vasopressin in isolated segments from branches (500-700 mu-m in external diameter) of human middle cerebral arteries obtained during autopsy of 15 patients who had died 3-8 hours before. Paired segments, one normal and the other de-endothelized by gentle rubbing, were mounted for isometric recording of tension in organ baths. In 11 normal segments, vasopressin produced concentration-dependent contractions with an EC50 of 7.0 x 10(-10) M. Removal of the endothelium from 12 segments did not significantly affect vasopressin-induced contractions. Vasopressin produced further contractions in arterial segments with (n = 4) or without (n = 5) endothelium precontracted with KCl. In segments precontracted with prostaglandin F2-alpha, acetylcholine caused relaxation only of those with endothelium. At 10(-8) M (n = 11), the vasopressin V-1 receptor antagonist d(CH2)5Tyr(Me)AVP produced a 60-fold shift to the right of the control response curve for vasopressin. Increasing the concentration of the receptors antagonist to 10(-6) M (n = 7) further displaced the control curve in a parallel manner. These results indicate that vasopressin exerts a powerful constrictor action on isolated human cerebral arteries by direct stimulation of V-1 receptors located predominantly on smooth muscle cells. It appears that this contractile response is not modulated by the presence of an intact endothelial cell layer.
引用
收藏
页码:1689 / 1693
页数:5
相关论文
共 35 条
  • [1] ALTURA BM, 1984, FED PROC, V43, P80
  • [2] ALTURA BM, 1977, FED PROC, V36, P1853
  • [3] HEMODYNAMIC AND COAGULATION RESPONSES TO 1-DESAMINO[8-D-ARGININE] VASOPRESSIN IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS
    BICHET, DG
    RAZI, M
    LONERGAN, M
    ARTHUS, MF
    PAPUKNA, V
    KORTAS, C
    BARJON, JN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14) : 881 - 887
  • [4] BUIJS RM, 1978, CELL TISSUE, V192, P523
  • [5] INCREASED ENDOTHELIAL CELL TURNOVER IN AREAS OF IN-VIVO EVANS-BLUE UPTAKE IN PIG AORTA
    CAPLAN, BA
    SCHWARTZ, CJ
    [J]. ATHEROSCLEROSIS, 1973, 17 (03) : 401 - 417
  • [6] CONDE MV, 1981, J CEREB BLOOD FLOW M, V1, pS350
  • [7] CONDE MV, 1983, J CEREB BLOOD FLOW M, V3, pS522
  • [8] EVIDENCE AND QUANTIFICATION OF THE VASOPRESSIN ARTERIAL-PRESSURE CONTROL-SYSTEM IN THE DOG
    COWLEY, AW
    SWITZER, SJ
    GUINN, MM
    [J]. CIRCULATION RESEARCH, 1980, 46 (01) : 58 - 67
  • [9] EFFECTS OF ARGININE VASOPRESSIN ON CEREBRAL MICROVASCULAR PRESSURE
    FARACI, FM
    MAYHAN, WG
    SCHMID, PG
    HEISTAD, DD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (01): : H70 - H76
  • [10] FLEMING WW, 1972, J PHARMACOL-PARIS, V181, P339